Biotech Essentials

Companies & Industries

Biotech Companies & Industries Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 23.06.2021.

#BIODigital
#GoodDayBIO
#ai
#biopharma
#stockmarket
#YogaDay
#medicalnews
#YogaDay2021
#IYD2021
#YogaForWellness

Companies And Industries

@BIOConvention shared
On Jun 22, 2021
RT @IAmBiotech: Need to catch up on #BIODigital or relive some of your favorite moments of the events? Select sessions are now available on demand on the Best of BIO: https://t.co/yx3jjTnuxO
Open
Best of BIO

Best of BIO

The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services.

@matthewherper shared
On Jun 17, 2021
"There is enormous capacity to do things better," says Doug Cole. "Sometimes it takes a crisis to bring that out." Watch: https://t.co/HmRG8PEs1I
Open
Virtual Event – Biotech: Where are we now?

Virtual Event – Biotech: Where are we now?

STAT's Kate Sheridan sits down with biotech leaders Doug Cole and Helen Torley to discuss where the industry is headed next.

@biospace shared
On Jun 23, 2021
Hong Kong biotech scores $255 million to take first AI-discovered candidate to clinic #ai #medicalnews https://t.co/5i25mWTTY2
Open
Hong Kong Biotech Scores $255 Million to Take First AI-Discovered Candidate to Clinic

Hong Kong Biotech Scores $255 Million to Take First AI-Discovered Candidate to Clinic

Founded in 2014, Insilico focuses on using artificial intelligence for drug discovery and development.

@KBIBiopharma shared
On Jun 17, 2021
“We are proud to have grown alongside our partners and to play an integral role in the development and manufacture of therapies that represent true advances to the treatment landscape for patients in need.” - KBI President & CEO Dirk Lange https://t.co/DnrpsJBeJz
Open
KBI Biopharma Enters Commercial Manufacturing Agreement with AM-Pharma to Prepare for the Commercial Launch of Lead Program in Acute Kidney Disease

KBI Biopharma Enters Commercial Manufacturing Agreement with AM-Pharma to Prepare for the Commercial Launch of Lead Program in Acute Kidney Disease

KBI Biopharma Enters Commercial Manufacturing Agreement with AM-Pharma to Prepare for the Commercial Launch of Lead Program in Acute Kidney Disease

@biospace shared
On Jun 18, 2021
Push to public continues as Biotech dominates the IPO list this week #stockmarket #biopharma https://t.co/iU6fdaqDyR
Open
Push to Public Continues as Biotech Dominates the IPO List This Week

Push to Public Continues as Biotech Dominates the IPO List This Week

Biotech companies are dominating Nasdaq’s IPO scheduled this week. Here’s who is making their big public debut.

@BIRAC_2012 shared
On Jun 22, 2021
RT @DBTIndia: International Day of #Yoga Celebrated by the @DBTIndia and its Autonomous Institutes Press Release: https://t.co/rOpvRgL7ui @drharshvardhan @RenuSwarup #YogaDay #YogaDay2021 #YogaForWellness #IYD2021 https://t.co/hCKM4Wn1Kf
Open
International Day of Yoga Celebrated by the Department of Biotechnology

International Day of Yoga Celebrated by the Department of Biotechnology

The Department of Biotechnology, Ministry of Science and Technology, Government of India and its Aut

@IAmBiotech shared
On Jun 18, 2021
#GoodDayBIO: Wrapping up #BIODigital week with a look at BIO’s new report on #DEI in our member companies – plus why solving #ClimateChange is a public health and social justice issue. https://t.co/ieIg52EuGQ
Open
Good Day BIO: DEI in biotech, by the numbers | BIO

Good Day BIO: DEI in biotech, by the numbers | BIO

We’re wrapping up BIO Digital Week with a look at BIO’s timely new report on diversity, equity, inclusion in our member companies—plus why solving climate change is a public health and ...

@BioWorld shared
On Jun 22, 2021
M&A values down by 76%; COVID-19 grasp on deals dropping… https://t.co/h4R9cr6qex
Open
M&A values down by 76%; COVID-19 grasp on deals dropping

M&A values down by 76%; COVID-19 grasp on deals dropping

While biopharma deals are very much in line with the early pandemic months of 2020, mergers and acquisitions are telling a different story – one in which values are down by 76%. As of June ...